Evidence map›Paper›PMID 42180819›Full record

ArticleKidney international reports2026

Randomized Trial of Finerenone on Urinary Albumin-to-Creatinine Ratio in Type 2 Diabetes Mellitus and CKD.

Atsushi Tanaka, Takumi Imai, Muthiah Vaduganathan, Yosuke Okada, Satomi Sonoda, Keiichi Torimoto, Satoru Suwa, Hiroki Teragawa, Motoaki Miyazono, Makoto Fukuda and 21 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors.

Atsushi TanakaDepartment of Cardiovascular Medicine, Saga University, Saga, Japan.
Takumi ImaiClinical Research Division, Organization for Clinical Medicine Promotion, Tokyo, Japan.
Muthiah VaduganathanDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Yosuke OkadaClinical Research Center, Hospital of the University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
Satomi SonodaFirst Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
Keiichi TorimotoFirst Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
Satoru SuwaDepartment of Cardiology, Juntendo University Shizuoka Hospital, Izunokuni, Japan.
Hiroki TeragawaDepartment of Cardiovascular Medicine, JR Hiroshima Hospital, Hiroshima, Japan.
Motoaki MiyazonoDepartment of Nephrology, Saga University, Saga, Japan.
Makoto FukudaDepartment of Nephrology, Saga University, Saga, Japan.
Keisuke YonezuDepartment of Cardiology and Clinical Examination, Faculty of Medicine, Oita University, Yufu, Japan.
Naohiko TakahashiDepartment of Cardiology and Clinical Examination, Faculty of Medicine, Oita University, Yufu, Japan.
Yuichi YoshidaDepartment of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Yufu, Japan.
Kenichi TanakaWakamatsu Hospital of the University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.
Michio ShimabukuroDepartment of Diabetes, Endocrinology, and Metabolism, Fukushima Medical University School of Medicine, Fukushima, Japan.
Yuki HottaDepartment of Diabetes, Endocrinology, and Metabolism, Fukushima Medical University School of Medicine, Fukushima, Japan.
Masao MoroiDivision of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo, Japan.
Hiroki NiikuraDivision of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo, Japan.
Keisuke KidaDepartment of Pharmacology, St. Marianna University School of Medicine, Kawasaki, Japan.
Kenichi YokotaDivision of Metabolism and Endocrinology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Daiju FukudaDepartment of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Kengo TanabeDivision of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan.
Yu HoriuchiDivision of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan.
Shigeru ToyodaDepartment of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan.
Isao TaguchiDepartment of Cardiology, Dokkyo Medical University Saitama Medical Center, Koshigaya, Japan.
Hisako YoshidaDepartment of Medical Statistics, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Toru MiyoshiDepartment of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Masaomi NangakuDivision of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
Hirotaka ShibataDepartment of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Yufu, Japan.
Koichi NodeDepartment of Cardiovascular Medicine, Saga University, Saga, Japan.
FIVE-STAR Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chronic kidney diseasecombination therapyfinerenoneglucagon-like peptide-1 receptor agonistsodium-glucose cotransporter 2 inhibitorurinary albumin excretion

Identifiers

PMID42180819
PMCPMC13195771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.